Cross-Border M&A: When Jurisdictions Collide

by Thomas Hargreaves, M&A Practice M&A 8 min read
Cross-Border M&A: When Jurisdictions Collide

Cross-border M&A transactions test the limits of legal infrastructure. They require simultaneous command of deal mechanics, regulatory clearance strategy, antitrust defense, foreign investment review, employment law harmonization, and tax structure — in multiple languages, under multiple legal systems, with multiple sets of advisors who will disagree about almost everything.

The transactions that succeed are those in which a single strategic intelligence commands all of these workstreams simultaneously. The transactions that fail — often expensively — are those in which each jurisdiction is managed independently, without a unified view of how the pieces interact.

The Regulatory Matrix

Every cross-border transaction of material size requires antitrust and foreign investment clearance in each jurisdiction where the parties have significant operations or sales. A merger between a U.S. technology company and a European industrial group may require notification to the DOJ or FTC, the European Commission, the UK CMA, and potentially a dozen additional competition authorities in Asia and Latin America.

Each authority applies its own substantive test, its own procedural timeline, and its own remedies toolkit. The European Commission applies a dominance test under SMIR that differs structurally from the DOJ’s substantial lessening of competition analysis. The UK CMA, now fully independent post-Brexit, has demonstrated willingness to block transactions that clear European review. The CFIUS process in the United States applies a national security analysis that is fundamentally different from antitrust review and that can block transactions on grounds entirely unrelated to competition.

Sophisticated pre-deal regulatory strategy requires mapping the full regulatory matrix before signing, identifying the jurisdictions likely to impose substantive requirements, designing transaction structures that minimize clearance risk, and sequencing the regulatory process to prevent any single authority from becoming a blocking proceeding.

CFIUS: The Invisible Veto

The Committee on Foreign Investment in the United States exercises jurisdiction over foreign acquisitions of U.S. businesses that implicate national security. Since FIRRMA’s enactment in 2018, CFIUS’s jurisdiction has expanded dramatically — it now covers transactions involving U.S. businesses dealing in critical technologies, critical infrastructure, or sensitive personal data, even where the foreign acquirer obtains only a minority stake.

Deals that do not require CFIUS notification can still be reviewed by the Committee on its own initiative, for up to five years post-closing. The consequence of a CFIUS-ordered divestiture after closing is severe: a forced sale under time pressure, into a known-seller market, with no ability to negotiate commercial terms.

The practical implication for cross-border M&A: CFIUS analysis should be conducted at the earliest stage of deal evaluation for any transaction involving a foreign acquirer and a U.S. target with technology, data, or infrastructure operations. The question is not whether to engage CFIUS — it is whether to engage voluntarily, on your terms, or to be reviewed involuntarily, on theirs.

Cross-border due diligence requires more than translating documents. It requires understanding the legal implications of what the documents reveal within each applicable system.

A warranty and indemnity structure that is standard in English law transactions — where seller representations are comprehensive, qualified by a disclosure letter, and backed by W&I insurance — operates very differently from a German transaction where representations are narrower, legal warranties arise by statute, and W&I insurance penetration is lower. A U.S. target’s employment agreements will contain at-will termination provisions that are legally meaningless in the target’s German or French operations, where statutory protections govern.

Environmental liability in particular requires jurisdiction-specific analysis. The U.S. CERCLA regime imposes joint and several liability on current owners for historical contamination without regard to fault. European environmental regimes vary substantially in their liability allocation between buyer and seller. The difference can be worth hundreds of millions of dollars in deal value.

Governing Law and Dispute Resolution Architecture

A cross-border transaction requires a hierarchy of governing law and dispute resolution mechanisms that covers: the purchase agreement itself; the representations and warranties; the post-closing adjustment mechanisms; the earn-out provisions; and the ancillary agreements including transitional service agreements, licenses, and employment arrangements.

The purchase agreement governing law and dispute resolution seat should be selected to maximize predictability, enforcement access, and judicial sophistication. English law governed agreements with London arbitration or LCIA proceedings provide strong cross-border enforcement under the New York Convention and access to English courts for urgent injunctive relief. New York law and SDNY or AAA arbitration are appropriate for transactions where U.S. counterparties are more comfortable with domestic procedures.

The governing law for employment, real property, and regulatory matters must follow the jurisdiction of the relevant assets and obligations — there is no alternative. The transaction structure must accommodate this fragmentation while maintaining a clear hierarchy of authority when legal systems conflict.

The Communication of Certainty

Beyond the technical legal execution, cross-border transactions require a discipline that is often undervalued: the management of regulatory and legal uncertainty in communications to boards, shareholders, and markets.

Companies that announce transactions with inadequate certainty analysis — that discover material regulatory obstacles after signing — create the worst possible commercial outcome: a deal that is stranded between signing and closing, with uncertainty compounding by the month.

The optimal approach is to delay announcement until the regulatory strategy is mapped, the material obstacles are understood, and the timeline is defensible. Transactions that close on schedule, without material modification, are the ones that were designed to do so before they were announced.

Cross-border M&A is not a test of deal speed. It is a test of structural command.